ACTRN12613000158763
Active, not recruiting
Phase 2
Evaluation treatment efficacy of citalopram, synbiotic, and mebeverine for children with functional abdominal pain; a randomized, placebo-controlled study.
Isfahan University of medical silences0 sites200 target enrollmentFebruary 11, 2013
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Isfahan University of medical silences
- Enrollment
- 200
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children between 6 to 18 years old, having functional abdominal pain according to ROME III criteria, having not consumption of probiotics and antibiotics in previous 2 months
Exclusion Criteria
- •Having gasterointestinal problems rather than functional abdomainal pain,
- •Patients who will not use three tablets
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Efficacy of citalopram and sertraline in depression according to BDNF, IL-6, and cortisol levelsIRCT20090117001556N147Tehran University of Medical Sciences80
Recruiting
Phase 3
Effect of Citalopram on EndometriosisIRCT20180211038692N2Tehran University of Medical Sciences80
Completed
Phase 2
Citaloparam in migraine prophylaxsisIRCT20161103030680N9Shahed University226
Recruiting
Phase 2
A comparative study of the effect of citalopram in the prevention of delirium in intubated patients without brain damage in Labafinejad Hospital ICIRCT20190215042716N6Shahid Beheshti University of Medical Sciences62
Active, not recruiting
Phase 1
A trial to investigate the effect of citalopram for the treatment of typical reflux symptomsEUCTR2017-004174-34-BETargid, KU Leuven100